Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind